Roughly 30,000 Americans are diagnosed with multiple myeloma each year—a rare but serious cancer of the plasma cells. Historically treated with chemotherapy, patients often faced recurring disease and…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
Acute tubular necrosis (ATN) is a type of renal azotemia caused by damage to the kidney tubules, leading to cell death. Ischemia, sepsis, heavy metals, and medications can…
Cathy Parkes, RN, reviews polycythemia and coagulation disorders, covering their causes, symptoms, lab findings, and treatments. Polycythemia is a rare blood disorder involving increased red blood cell production,…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder where antibodies target platelets, leading to their destruction in the spleen and resulting in reduced platelet counts. It often presents…
